|Bid||423.00 x 100|
|Ask||474.00 x 200|
|Day's Range||428.48 - 436.57|
|52 Week Range||217.19 - 436.57|
|PE Ratio (TTM)||55.93|
|Earnings Date||Jan 25, 2018|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||407.53|
Zacks.com highlights: Caterpillar, Crocs, Pioneer Natural Resources, Legg Mason and Intuitive Surgical
Becton, Dickinson's (BDX) focus in the Balloon-Angioplasty space is expected to lend the company a competitive edge in the niche MedTech markets.
While Intuitive Surgical showed why late-stage bases are an excellent topping signal, it also proves how some great companies can eventually lead again.
McKesson (MCK) continues to pursue deals, divestitures and acquisitions to drive growth. The company's impressive performance in 2017 accounts for its potential to sustain the momentum.
Intuitive Surgical (ISRG) is expected to witness growth across da Vinci Surgical and Service segments. Instruments and accessories revenues are also expected to increase year over year.
Myriad Genetics (MYGN) has been leaving no stone unturned to boost the uptake of BRACAnalysis CDx test and strengthen the Molecular Diagnostics portfolio.
To get ready for earnings season, look for stocks in or near a potential buy range ahead of their next quarterly report. One such company is Intuitive Surgical[ticker symb=ISRG]. It's expected to report on Jan. 22. The stock is approximately 5% above a 405.15 buy point from a second-stage flat base. Be aware that buying close to when a stock...